Cart
sales@molnova.com
Reynoutrin
CAS No. 549-32-6
Reynoutrin( Quercetin-3-D-xyloside | Reinutrin )
Catalog No. M21060 CAS No. 549-32-6
Reynoutrin with antioxidant and radical-scavenging activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 136 | In Stock |
|
| 5MG | 122 | In Stock |
|
| 10MG | 183 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 445 | In Stock |
|
| 100MG | 638 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameReynoutrin
-
NoteResearch use only, not for human use.
-
Brief DescriptionReynoutrin with antioxidant and radical-scavenging activity.
-
DescriptionReynoutrin with antioxidant and radical-scavenging activity.
-
In VitroReynoutrin shows potent antioxidant activity, with pEC50 of 5.37 against fluorescein oxidation.
-
In Vivo——
-
SynonymsQuercetin-3-D-xyloside | Reinutrin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number549-32-6
-
Formula Weight434.35
-
Molecular FormulaC20H18O11
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL (345.34 mM)
-
SMILESO=c1c(O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ho R Violette et al. Antioxidant potential and radical-scavenging effects of flavonoids from the leaves of Psidium cattleianum grown in French Polynesia[J]. Natural Product Research 2012.
molnova catalog
related products
-
Dimethylmatairesinol
Dimethylmatairesinol (compound 8) is a lignan compound isolated from the seed of Hernandia nymphaeifolia. Dimethylmatairesinol shows cytotoxicity against the KKU-M156 and HepG2 cell line with IC50s of 5.4 μM (Emax 59%) and 5.2 μM (Emax 78%), respectively.
-
CB-TH
CB-TH
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
